Literature DB >> 1609565

Prevalence of retinitis pigmentosa and allied disorders in Denmark. I Main results.

M Haim1, N V Holm, T Rosenberg.   

Abstract

In a nation-wide study we utilized all available sources to characterize the prevalence rates of retinitis pigmentosa. 1301 persons, 715 males and 586 females, were identified, with a diagnosis of retinitis pigmentosa or some other tapetoretinal dystrophy, and living in Denmark per January 1, 1988. The corresponding completeness corrected prevalence rate of retinitis pigmentosa was 1:3026. All cases were classified as 'certain', 'probable', or 'possible'. The age specific prevalence rates increased until 40-50 years, reaching a level of 35-40 male cases per 100,000 and 25-30 female cases per 100,000. Age specific prevalence rates were standardized to the WHO World Standard Population and compared to rates reported from Britain and The United States. World standardized prevalence rate for males was 25.29 per 100,000 and for females 19.31 per 100,000. The preponderance of males was highly statistically significant, (P less than 0.01).

Entities:  

Mesh:

Year:  1992        PMID: 1609565     DOI: 10.1111/j.1755-3768.1992.tb04121.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  15 in total

1.  Clinical studies on progressive retinal atrophy in 31 dogs.

Authors:  D N Kelawala; D B Patil; P V Parikh; M J Sheth; C G Joshi; B Reddy
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

2.  Identification of putative SNPs in progressive retinal atrophy affected Canis lupus familiaris using exome sequencing.

Authors:  Bhaskar Reddy; Divyesh N Kelawala; Tejas Shah; Anand B Patel; Deepak B Patil; Pinesh V Parikh; Namrata Patel; Nidhi Parmar; Amit B Mohapatra; Krishna M Singh; Ramesh Menon; Dipal Pandya; Subhash J Jakhesara; Prakash G Koringa; Mandava V Rao; Chaitanya G Joshi
Journal:  Mamm Genome       Date:  2015-10-29       Impact factor: 2.957

3.  Serum retinoids in retinitis pigmentosa patients treated with vitamin A.

Authors:  G A Fex; S Andréasson; B Ehinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

4.  ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.

Authors:  Eliot L Berson; Bernard Rosner; Michael A Sandberg; Carol Weigel-DiFranco; Walter C Willett
Journal:  Arch Ophthalmol       Date:  2012-06

5.  Hereditary and clinical features of retinitis pigmentosa in Koreans.

Authors:  Sun Ho Lee; Hyeong Gon Yu; Jong Mo Seo; Sang Woong Moon; Jun Woong Moon; Sang Jin Kim; Hum Chung
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

6.  The role of fundus autofluorescence in late-onset retinitis pigmentosa (LORP) diagnosis.

Authors:  Tamara J Lee; John C Hwang; Royce W S Chen; Luiz H Lima; Nan-Kai Wang; Joaquin Tosi; K Bailey Freund; Lawrence A Yannuzzi; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2013-07-30       Impact factor: 1.803

7.  Novel deletion in the pre-mRNA splicing gene PRPF31 causes autosomal dominant retinitis pigmentosa in a large Chinese family.

Authors:  Lejin Wang; Michael Ribaudo; Kanxing Zhao; Ning Yu; Qiuyun Chen; Qiuxiang Sun; Liming Wang; Qing Wang
Journal:  Am J Med Genet A       Date:  2003-09-01       Impact factor: 2.802

8.  Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.

Authors:  Francesco Parmeggiani; Giovanni Sato; Katia De Nadai; Mario R Romano; Andrea Binotto; Ciro Costagliola
Journal:  Curr Genomics       Date:  2011-06       Impact factor: 2.236

9.  Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking.

Authors:  Marzio Chizzolini; Alessandro Galan; Elisabeth Milan; Adolfo Sebastiani; Ciro Costagliola; Francesco Parmeggiani
Journal:  Curr Genomics       Date:  2011-06       Impact factor: 2.236

10.  A frameshift mutation in golden retriever dogs with progressive retinal atrophy endorses SLC4A3 as a candidate gene for human retinal degenerations.

Authors:  Louise M Downs; Berit Wallin-Håkansson; Mike Boursnell; Stefan Marklund; Åke Hedhammar; Katarina Truvé; Louise Hübinette; Kerstin Lindblad-Toh; Tomas Bergström; Cathryn S Mellersh
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.